137 related articles for article (PubMed ID: 23231799)
21. Screening and adenocarcinoma of the cervix.
Sasieni P; Castanon A; Cuzick J
Int J Cancer; 2009 Aug; 125(3):525-9. PubMed ID: 19449379
[TBL] [Abstract][Full Text] [Related]
22. Trends in cervical and breast cancer in Iceland. A statistical evaluation of trends in incidence and mortality for the period 1955-1989, their relation to screening and prediction to the year 2000.
Sigurdsson K; Adalsteinsson S; Ragnarsson J
Int J Cancer; 1991 Jun; 48(4):523-8. PubMed ID: 2045199
[TBL] [Abstract][Full Text] [Related]
23. A longitudinal Swedish study on screening for squamous cell carcinoma and adenocarcinoma: evidence of effectiveness and overtreatment.
Gunnell AS; Ylitalo N; Sandin S; Sparén P; Adami HO; Ripatti S
Cancer Epidemiol Biomarkers Prev; 2007 Dec; 16(12):2641-8. PubMed ID: 18086769
[TBL] [Abstract][Full Text] [Related]
24. Etiologic heterogeneity for cervical carcinoma by histopathologic type, using comparative age-period-cohort models.
Reimers LL; Anderson WF; Rosenberg PS; Henson DE; Castle PE
Cancer Epidemiol Biomarkers Prev; 2009 Mar; 18(3):792-800. PubMed ID: 19258470
[TBL] [Abstract][Full Text] [Related]
25. [Diagnosis and treatment of invasive cervical cancer in Cambodia (apropos of 35 cases)].
Monchy D; Lieng CR; Kruy LS; Kahler K; Eav S
Bull Soc Pathol Exot; 2005 Sep; 98(3):183-6. PubMed ID: 16267957
[TBL] [Abstract][Full Text] [Related]
26. Is cervical screening preventing adenocarcinoma and adenosquamous carcinoma of the cervix?
Castanon A; Landy R; Sasieni PD
Int J Cancer; 2016 Sep; 139(5):1040-5. PubMed ID: 27096255
[TBL] [Abstract][Full Text] [Related]
27. Risk of invasive cervical cancer after three consecutive negative Pap smears.
Coldman A; Phillips N; Kan L; Matisic J; Benedet L; Towers L
J Med Screen; 2003; 10(4):196-200. PubMed ID: 14738657
[TBL] [Abstract][Full Text] [Related]
28. Follow-up of women with cervical cytological abnormalities showing atypical squamous cells of undetermined significance or low-grade squamous intraepithelial lesion: a nationwide cohort study.
Sundström K; Lu D; Elfström KM; Wang J; Andrae B; Dillner J; Sparén P
Am J Obstet Gynecol; 2017 Jan; 216(1):48.e1-48.e15. PubMed ID: 27457115
[TBL] [Abstract][Full Text] [Related]
29. Reducing the burden of glandular carcinomas of the uterine cervix.
Herzog TJ; Monk BJ
Am J Obstet Gynecol; 2007 Dec; 197(6):566-71. PubMed ID: 18060938
[TBL] [Abstract][Full Text] [Related]
30. Squamous cell carcinoma of the cervix: a cytology-histology-human papillomavirus correlation in clinical practice.
Miller RA; Waters LL; Mody DR; Tams KC
Arch Pathol Lab Med; 2015 Jun; 139(6):776-81. PubMed ID: 26030246
[TBL] [Abstract][Full Text] [Related]
31. Cervical cancer incidence in Denmark over six decades (1943-2002).
Kyndi M; Frederiksen K; Krüger Kjaer S
Acta Obstet Gynecol Scand; 2006; 85(1):106-11. PubMed ID: 16521689
[TBL] [Abstract][Full Text] [Related]
32. Cervical cancer screening. Organised screening to avoid unnecessary conisation.
Prescrire Int; 2010 Aug; 19(108):172-7, 179. PubMed ID: 20939454
[TBL] [Abstract][Full Text] [Related]
33. Cervical cancer in South Australia: trends in incidence, mortality and case survival.
Bonett A; Davy M; Roder D
Aust N Z J Obstet Gynaecol; 1989 Aug; 29(3 Pt 1):193-6. PubMed ID: 2604645
[TBL] [Abstract][Full Text] [Related]
34. Uterine cervical adenocarcinomas and squamous carcinomas in Bombay: 1965-1990.
Krishnamurthy S; Yecole BB; Jussawalla DJ
J Obstet Gynaecol Res; 1997 Dec; 23(6):521-7. PubMed ID: 9433043
[TBL] [Abstract][Full Text] [Related]
35. The impact of the National Cervical Screening Programme on the presentation of cancer of the cervix in Canterbury.
Simcock B; Sykes P; Laney M
N Z Med J; 2001 Aug; 114(1138):378-80. PubMed ID: 11589435
[TBL] [Abstract][Full Text] [Related]
36. Pap test use and cervical cancer incidence in First Nations women living in Manitoba.
Decker KM; Demers AA; Kliewer EV; Biswanger N; Musto G; Elias B; Griffith J; Turner D
Cancer Prev Res (Phila); 2015 Jan; 8(1):49-55. PubMed ID: 25403849
[TBL] [Abstract][Full Text] [Related]
37. Human papillomavirus genotype attribution in invasive cervical cancer: a retrospective cross-sectional worldwide study.
de Sanjose S; Quint WG; Alemany L; Geraets DT; Klaustermeier JE; Lloveras B; Tous S; Felix A; Bravo LE; Shin HR; Vallejos CS; de Ruiz PA; Lima MA; Guimera N; Clavero O; Alejo M; Llombart-Bosch A; Cheng-Yang C; Tatti SA; Kasamatsu E; Iljazovic E; Odida M; Prado R; Seoud M; Grce M; Usubutun A; Jain A; Suarez GA; Lombardi LE; Banjo A; Menéndez C; Domingo EJ; Velasco J; Nessa A; Chichareon SC; Qiao YL; Lerma E; Garland SM; Sasagawa T; Ferrera A; Hammouda D; Mariani L; Pelayo A; Steiner I; Oliva E; Meijer CJ; Al-Jassar WF; Cruz E; Wright TC; Puras A; Llave CL; Tzardi M; Agorastos T; Garcia-Barriola V; Clavel C; Ordi J; Andújar M; Castellsagué X; Sánchez GI; Nowakowski AM; Bornstein J; Muñoz N; Bosch FX;
Lancet Oncol; 2010 Nov; 11(11):1048-56. PubMed ID: 20952254
[TBL] [Abstract][Full Text] [Related]
38. Trends in incidence of and mortality from invasive cancer of the uterine cervix in Scotland (1975-1994).
Walker JJ; Brewster D; Gould A; Raab GM
Public Health; 1998 Nov; 112(6):373-8. PubMed ID: 9883033
[TBL] [Abstract][Full Text] [Related]
39. Trends in cancer of the cervix uteri in Sweden following cytological screening.
Bergström R; Sparén P; Adami HO
Br J Cancer; 1999 Sep; 81(1):159-66. PubMed ID: 10487628
[TBL] [Abstract][Full Text] [Related]
40. Changes in cervical cancer incidence following the introduction of organized screening in Italy.
Serraino D; Gini A; Taborelli M; Ronco G; Giorgi-Rossi P; Zappa M; Crocetti E; Franzo A; Falcini F; Visioli CB; Stracci F; Zorzi M; Federico M; Michiara M; Fusco M; Ferretti S; Pannozzo F; Tisano F; Zanetti R; Zucchetto A; ;
Prev Med; 2015 Jun; 75():56-63. PubMed ID: 25818232
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
